Rubin Jonathan

Rubin Jonathan is listed in filings as SVP at Supernus Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Feb 26, 2026, including sale activity. Recent filings connect the profile to Supernus Pharmaceuticals, Inc. (SUPN). The current snapshot covers public activity from Feb 24, 2025 to Feb 26, 2026. Reported amounts are shown as $34.2K to $18.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.